Webinar on Cannabidiol and Epilepsy – An FDA Approved Therapy

Webinar on Wednesday, October 10, 8:00 to 9:00 p.m. ET

Join us for a webinar on Wednesday, October 10, 2018, to learn about cannabidiol (CBD) as a treatment for epilepsy. Epidiolex^® (a > 98% purified, oil-based CBD extract from the cannabis plant) was recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of Dravet and Lennox-Gastaut syndromes.

Webinar

• Date: October 10, 2018
• Time: 8:00 to 9:00 p.m. ET

Moderated by Dr. Elaine Kiriakopoulos, director of health communications and engagement for the Epilepsy Foundation, our speakers will discuss

• History and research behind CBD
• Safety and effectiveness
• What the FDA approval of CBD means for people with epilepsy and families

Guest Speakers

 

Joseph Sirven MD
Professor of Neurology
Chair Emeritus, Department of Neurology
Mayo Clinic, Arizona
Editor-In-Chief, epilepsy.com

 

Barry Gidal PharmD
Professor of Pharmacy and Neurology
University of Wisconsin - Madison
Epilepsy Foundation Professional Advisory Board
Medication Editor, epilepsy.com

 

Anup Patel MD
Associate Professor, Neurology and Pediatrics
Nationwide Children's Hospital
Ohio State University Medical Center
Medical Cannabis Editor, epilepsy.com

Note: presenters cannot address individual medical concerns and cannot provide individual advice.